Case Study: Pharmaceutical Company prevents domain spoofing and reduces credential phishing to near zero with Fortra (Agari DMARC Protection)

A Fortra Case Study

Preview of the Pharmaceutical Company Case Study

Pharmaceutical Company Prevents Domain Spoofing with Agari DMARC Protection

A global pharmaceutical company in the industrial absorbents space with a complex Microsoft 365 email environment faced widespread credential-phishing and domain-impersonation attacks that threatened brand reputation and customer trust. The security team required a fast move to a DMARC p=reject policy across dozens of domains to stop spoofing and protect customers from financially motivated scams.

They deployed Agari DMARC Protection to enforce authentication across ~40 domains and manage numerous external senders, reaching p=reject in five months—beating their six-month target. The result: credential-stealing and impersonation attacks dropped to near zero, the InfoSec team regained time and productivity, and the company strengthened customer confidence by demonstrating a world-class security posture.


Open case study document...

Fortra

376 Case Studies